Follow
A/Prof Vivek Naranbhai
Title
Cited by
Cited by
Year
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
WF Garcia-Beltran, EC Lam, KS Denis, AD Nitido, ZH Garcia, BM Hauser, ...
Cell 184 (9), 2372-2383. e9, 2021
14932021
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
WF Garcia-Beltran, KJS Denis, A Hoelzemer, EC Lam, AD Nitido, ...
Cell 185 (3), 457-466. e4, 2022
10222022
Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression
BP Fairfax, P Humburg, S Makino, V Naranbhai, D Wong, E Lau, L Jostins, ...
Science 343 (6175), 1246949, 2014
8062014
Genital inflammation and the risk of HIV acquisition in women
L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ...
Clinical Infectious Diseases 61 (2), 260-269, 2015
4302015
T-cell activation is an immune correlate of risk in BCG vaccinated infants
HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ...
Nature communications 7 (1), 11290, 2016
2902016
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
V Naranbhai, A Nathan, C Kaseke, C Berrios, A Khatri, S Choi, MA Getz, ...
Cell 185 (6), 1041-1051. e6, 2022
2552022
Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel
V Naranbhai, SS Abdool Karim, M Altfeld, N Samsunder, R Durgiah, ...
The Journal of infectious diseases 206 (7), 993-1001, 2012
1662012
Genomic modulators of gene expression in human neutrophils
V Naranbhai, BP Fairfax, S Makino, P Humburg, D Wong, E Ng, AVS Hill, ...
Nature communications 6 (1), 7545, 2015
1572015
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells
V Ramsuran, V Naranbhai, A Horowitz, Y Qi, MP Martin, Y Yuki, X Gao, ...
Science 359 (6371), 86-90, 2018
1492018
Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy
V Naranbhai, AVS Hill, SS Abdool Karim, K Naidoo, Q Abdool Karim, ...
The Journal of infectious diseases 209 (4), 500-509, 2014
1382014
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26. COV2. S COVID-19 vaccines
V Naranbhai, WF Garcia-Beltran, CC Chang, C Berrios Mairena, ...
The Journal of infectious diseases 225 (7), 1141-1150, 2022
1262022
A systematic review of definitions of extreme phenotypes of HIV control and progression
D Gurdasani, L Iles, DG Dillon, EH Young, AD Olson, V Naranbhai, ...
Aids 28 (2), 149-162, 2014
1192014
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome
CC Chang, AA Dorasamy, BI Gosnell, JH Elliott, T Spelman, S Omarjee, ...
Aids 27 (13), 2089-2099, 2013
1122013
The association between the ratio of monocytes: lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life
V Naranbhai, S Kim, H Fletcher, MF Cotton, A Violari, C Mitchell, ...
BMC medicine 12, 1-6, 2014
1042014
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
S Kulkarni, A Lied, V Kulkarni, M Rucevic, MP Martin, V Walker-Sperling, ...
Nature immunology 20 (7), 824-834, 2019
932019
IFITM3 and Susceptibility to Respiratory Viral Infections in the Community
TC Mills, A Rautanen, KS Elliott, T Parks, V Naranbhai, MM Ieven, ...
The Journal of infectious diseases 209 (7), 1028-1031, 2014
852014
Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
V Naranbhai, HA Fletcher, R Tanner, MK O'Shea, H McShane, BP Fairfax, ...
EBioMedicine 2 (11), 1619-1626, 2015
812015
High seroprevalence of anti-SARS-CoV-2 antibodies in Chelsea, Massachusetts
V Naranbhai, CC Chang, WFG Beltran, TE Miller, MG Astudillo, ...
The Journal of infectious diseases 222 (12), 1955-1959, 2020
792020
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children
GM Warimwe, LM Murungi, G Kamuyu, GM Nyangweso, J Wambua, ...
PLoS One 8 (2), e57320, 2013
782013
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer: the CANVAX cohort study
V Naranbhai, CA Pernat, A Gavralidis, KJ St Denis, EC Lam, LM Spring, ...
Journal of Clinical Oncology 40 (1), 12, 2022
762022
The system can't perform the operation now. Try again later.
Articles 1–20